Literature DB >> 31272906

Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.

Sussy C Luperdi1, Rafael Tabarés-Seisdedos2, Lorenzo Livianos3, Eduard Vieta4, Manuel J Cuesta5, Vicent Balanzá-Martínez6.   

Abstract

Although there is substantial evidence supporting the existence of neurocognitive impairment in patients diagnosed with schizophrenia (SZ) and bipolar disorder (BD), few studies have explored the field from an endophenotypic perspective. The present systematic review sought to identify longitudinal family studies exploring suitable neurocognitive endophenotypes in unaffected relatives of patients with SZ and/or BD. Following the PRISMA statement, only five follow-up studies met the inclusion criteria, comprising 79 SZ patients, 159 SZ unaffected relatives of SZ, 131 BD patients, 77 unaffected relatives of BD, and 248 controls. Verbal memory, auditory attention, face memory and emotion processing were found as putative endophenotypic candidates for SZ, whereas this strategy identified none for BD. Substantial heterogeneity and lack of standardization in global neurocognitive assessment within this area should be pointed out; nevertheless, several candidate endophenotypes were identified for SZ, except for executive impairment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Cognitive impairment; Endophenotypes; Neurocognition; Schizophrenia; Unaffected relatives

Year:  2019        PMID: 31272906     DOI: 10.1016/j.schres.2019.06.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Social cognition in siblings of patients with bipolar disorders.

Authors:  Swati Choudhary; B N Subodh; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2021-06-24

2.  Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study.

Authors:  Elizabeth Ruiz-Sánchez; Janet Jiménez-Genchi; Yessica M Alcántara-Flores; Carlos J Castañeda-González; Carlos L Aviña-Cervantes; Petra Yescas; María Del Socorro González-Valadez; Nancy Martínez-Rodríguez; Antonio Ríos-Ortiz; Martha González-González; María E López-Navarro; Patricia Rojas
Journal:  BMC Psychiatry       Date:  2021-02-09       Impact factor: 3.630

3.  Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.

Authors:  R Méndez; V Balanzá-Martínez; S C Luperdi; I Estrada; A Latorre; P González-Jiménez; L Feced; L Bouzas; K Yépez; A Ferrando; D Hervás; E Zaldívar; S Reyes; M Berk; R Menéndez
Journal:  J Intern Med       Date:  2021-03-13       Impact factor: 13.068

4.  Neurobehavioral Dimensions of Prader Willi Syndrome: Relationships Between Sleep and Psychosis-Risk Symptoms.

Authors:  Kathleen P O'Hora; Zizhao Zhang; Ariana Vajdi; Leila Kushan-Wells; Zhengyi Sissi Huang; Laura Pacheco-Hansen; Elizabeth Roof; Anthony Holland; Ruben C Gur; Carrie E Bearden
Journal:  Front Psychiatry       Date:  2022-04-13       Impact factor: 5.435

Review 5.  Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models.

Authors:  Ramiro Reckziegel; Letícia S Czepielewski; Mathias Hasse-Sousa; Dayane S Martins; Maria J de Britto; Clara de O Lapa; Alexandre W Schwartzhaupt; Clarissa S Gama
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.